Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2014 by Sidney Kimmel Comprehensive Cancer Center.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Guerbet
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01877187
First received: March 27, 2013
Last updated: September 15, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)